See also this year's filing and all EDGAR filings for this company.
PDF Report 0001269021_2018_Portola_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001269021, Portola Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 477,923,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,217,000 |
| 3 | remainder_Assets | 88,536,000 |
| 4 | LiabilitiesCurrent | 80,524,000 |
| 5 | LiabilitiesNoncurrent | 64,296,000 |
| 6 | remainder_Liabilities | 77,363,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 91,109,000 |
| 9 | ResearchAndDevelopmentExpense | 203,701,000 |
| 10 | remainder_Expenses | 12,018,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 21,208,000 |
| 13 | remainder_ComprehensiveNetIncome | -867,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 571,676,000 |
| 1 | Liabilities | 222,183,000 |
| 2 | Expenses | 306,828,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 349,493,000 |
| 5 | NetIncome | -285,620,000 |
| 6 | ComprehensiveNetIncome | -286,053,500 |
| 7 | BaseVar | 561,381,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.20 |
| 9 | EconomicCapitalRatio | 2.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
